Do not start, stop, switch, or change the dose of a GLP-1 medication without guidance from the healthcare professional managing your treatment
And they accepted that the pace of progress would be slower during the active weight loss phase, and that slower progress is still progress
This approach supports steady weight loss, ideal for individuals aiming to lose a smaller amount of weight or improve overall health
While GLP-1 receptor agonist therapy leads to greater relative fat loss than lean mass loss, preserving muscle tissue requires adequate protein intake and resistance exercise during weight reduction
With FDA approval, resmetirom, a liver-targeted thyroid hormone receptor- (THR) selective agonist, changes the MASH drug development landscape
Our range of GLP-1 friendly shakes offer you nutritionally complete support, plus a range of additional active ingredients to help you achieve your body goals